Johnson & Johnson: U.S. regulators call for vaccine pause after blood clot reports

The CDC and FDA have issued a joint statement recommending a pause in the use of the Johnson & Johnson COVID-19 vaccine in the United States. The agencies say they are reviewing six reported cases of a rare type of blood clot in people who have received the vaccine. Nearly 7 million doses have already been administered in the country.